BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35093716)

  • 21. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
    Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
    Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene.
    Lu X; Song N; Wang W; Liu Y; Song H; Xu L; Wang Y; Wei C; Chen J; Yang X; Han F
    Stem Cell Res; 2021 Oct; 56():102514. PubMed ID: 34464855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
    Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35.
    Larsen SB; Hanss Z; Cruciani G; Massart F; Barbuti PA; Mellick G; Krüger R
    Stem Cell Res; 2020 May; 45():101776. PubMed ID: 32387898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
    Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
    Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
    Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
    Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient.
    Ma J; Guo R; Song Y; Zhang J; Feng B; Amponsah AE; Kong D; He J; Zhang W; Liu A; Wei L; Shen S; O'Brien T; Cui H
    Stem Cell Res; 2019 Apr; 36():101417. PubMed ID: 30875588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4.
    Jennings L; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2020 Oct; 48():101947. PubMed ID: 32810830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation.
    Wang Y; Wei C; Liu Y; Lu X; Wang W; Song N; Zhang W; Xu J; Zhang W; Han F
    Stem Cell Res; 2024 Jun; 77():103359. PubMed ID: 38460235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
    Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
    Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
    Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation.
    Murakami N; Ishikawa T; Kondo T; Imamura K; Tsukita K; Enami T; Funayama M; Shibukawa R; Matsumoto S; Izumi Y; Ohta E; Obata F; Kaji R; Inoue H
    Stem Cell Res; 2017 Oct; 24():36-39. PubMed ID: 29034893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
    Lee Y; Jeong D; Ham S; Son J; Ko K
    Stem Cell Res; 2024 Jun; 77():103416. PubMed ID: 38615589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of an induced pluripotent stem cell line (ZJUi007-A) from a 11-year-old patient of Fabry disease.
    Zhu Y; Zhang L; Wang G; Zhao J; Hou X; Wu H; Xu Y; Mao J; Liu Z; Zhang J
    Stem Cell Res; 2021 Aug; 55():102475. PubMed ID: 34365103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.